Drugs / Sulijia
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03117335 | Nov 2011 → Nov 2016 | non-small cell lung carcinoma | Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sulijia | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03117335 ↗ |